Stratos Genomics

About Stratos Genomics

Stratos Genomics is a pioneering company in the field of nanopore DNA sequencing technology. Utilizing their proprietary Sequencing by Expansion (SBX) method, Stratos Genomics aims to revolutionize the way DNA is sequenced. The core technology involves the use of Xpandomers, which are synthesized using highly engineered nucleotides called X NTPs. These Xpandomers, when passed through a nanopore, produce distinct electrical signals that allow for accurate identification of DNA bases. This method promises high-quality data with clear results and a high signal-to-noise ratio.

Stratos Genomics serves a wide range of clients, including researchers in genomics, healthcare providers, and pharmaceutical companies. The market it operates in is the next-generation sequencing (NGS) sector, which is rapidly growing due to the increasing demand for precise and rapid genomic analysis. The company's business model is based on providing cutting-edge sequencing technology and related services to its clients. Revenue is generated through the sale of sequencing instruments, consumables, and service contracts.

The technology developed by Stratos Genomics has broad applications, from targeted oncology panels and whole genome sequencing to the rapid diagnosis of infectious diseases. By leveraging advanced protein engineering and polymerase design, the company ensures that its sequencing technology is both versatile and reliable.